The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 10, 2026

Filed:

Apr. 10, 2023
Applicant:

Arion Diagnostics, Inc., Petaluma, CA (US);

Inventors:

Alexander P. Lazarev, Lake Forest, CA (US);

Delvin Tai Wai Yuk, Atherton, CA (US);

Pavel Lazarev, Box Elder, SD (US);

Assignee:

Arion Diagnostics, Inc., Petaluma, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 6/00 (2024.01); A61B 6/46 (2024.01); A61B 6/50 (2024.01); G06T 7/00 (2017.01); G16H 20/40 (2018.01); G16H 30/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
A61B 6/502 (2013.01); A61B 6/467 (2013.01); A61B 6/563 (2013.01); G06T 7/0012 (2013.01); G16H 20/40 (2018.01); G16H 30/20 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G06T 2207/10116 (2013.01); G06T 2207/30068 (2013.01);
Abstract

The present disclosure relates to determining a biological tissue structural marker for diagnosis of a disease using a biological tissue characterization technique. A method for determining a structural marker for a diagnosis of a disease can include measuring a first molecular structure of a biological tissue of a first population of animals, after a carcinogenic or pathogenic substance was introduced into the first population. A second molecular structure of the biological tissue of a second population of animals can be measured, wherein the second population did not receive the carcinogenic or pathogenic substance. A first and a second structural marker of the molecular structures of the biological tissue of the first and second populations, respectively, can be identified and compared to determine that the first structural marker is indicative that the biological tissue of the first population of animals was affected by the disease.


Find Patent Forward Citations

Loading…